Shares of JAN (NYSE:JAN – Get Free Report) have received a consensus rating of “Moderate Buy” from the eleven research firms that are currently covering the company, MarketBeat reports. One analyst has rated the stock with a hold rating and ten have given a buy rating to the company. The average 12 month target price among analysts that have issued ratings on the stock in the last year is $27.2727.
A number of research firms have recently commented on JAN. Scotiabank began coverage on shares of JAN in a research report on Tuesday. They set a “sector outperform” rating and a $28.00 price target for the company. Barclays assumed coverage on shares of JAN in a research report on Tuesday. They issued an “overweight” rating and a $26.00 target price for the company. Morgan Stanley assumed coverage on shares of JAN in a research report on Tuesday. They issued an “overweight” rating and a $28.00 target price for the company. Wells Fargo & Company assumed coverage on shares of JAN in a research report on Tuesday. They issued an “overweight” rating and a $27.00 target price for the company. Finally, Bank of America assumed coverage on shares of JAN in a research report on Tuesday. They issued a “buy” rating and a $29.00 target price for the company.
Get Our Latest Research Report on JAN
Key JAN News
- Positive Sentiment: KeyCorp reiterated an “Overweight” stance, published updated quarterly and FY2026–FY2027 EPS forecasts and a $28 price target — analyst model updates raise visible earnings expectations for 2026–27. KeyCorp / MarketBeat
- Positive Sentiment: Multiple Wall Street firms (Wells Fargo, RBC, BNP Paribas Exane, Barclays and others) released Overweight/Outperform ratings with targets clustered at $26–$28 — broad buy-side coverage and similar targets increase analyst-driven demand and liquidity.
- Positive Sentiment: New coverage initiations from Cantor Fitzgerald, Scotiabank, JPMorgan and Bank of America add institutional attention and distribution, which can support the stock if execution matches forecasts. Cantor Fitzgerald initiation: Cantor Fitzgerald Coverage — Scotiabank initiation: Scotiabank Coverage — JPMorgan initiation: JPMorgan Coverage — Bank of America initiation: BofA Coverage
- Neutral Sentiment: Goldman Sachs set a “Neutral” rating with ~the same $27 target — a mixed signal that tempers the uniformity of buy-side views and may limit upside from a single-note catalyst.
- Negative Sentiment: Fundamentally JAN still shows a negative trailing P/E (company unprofitable on a GAAP basis), which keeps valuation and execution risk front and center if earnings and margin improvements underperform analyst forecasts.
- Negative Sentiment: Despite the analyst interest, the stock is down intraday — likely short-term profit-taking or market/headline noise; watch volume and whether the new coverage leads to follow-through buying or more chop.
JAN Stock Down 1.6%
JAN opened at $25.73 on Tuesday. The firm has a market cap of $6.61 billion, a PE ratio of -62.29 and a beta of 2.16. JAN has a one year low of $22.76 and a one year high of $26.71.
Insider Buying and Selling
In other JAN news, COO Jeffrey H. Miller purchased 7,500 shares of the stock in a transaction on Monday, March 23rd. The stock was acquired at an average cost of $20.00 per share, with a total value of $150,000.00. Following the completion of the purchase, the chief operating officer directly owned 7,500 shares of the company’s stock, valued at approximately $150,000. This trade represents a ∞ increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Charles J. Herman, Jr. purchased 5,500 shares of the stock in a transaction on Monday, March 23rd. The stock was acquired at an average cost of $20.00 per share, with a total value of $110,000.00. Following the completion of the purchase, the director directly owned 13,000 shares of the company’s stock, valued at $260,000. The trade was a 73.33% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders bought 187,000 shares of company stock valued at $3,740,000 in the last three months. 3.00% of the stock is owned by corporate insiders.
JAN Company Profile
Upon completion of this offering, we will be the only U.S. publicly traded REIT focused exclusively on the senior housing sector and the only U.S. publicly traded REIT whose entire portfolio is owned and operated under RIDEA structures. We have an initial portfolio consisting of 34 senior housing communities, comprised of 10,422 units as of December 31, 2025. Our communities are located primarily in major retirement markets across 10 states, with units in Florida and Texas representing 69% of the total units as of December 31, 2025.
Featured Stories
Receive News & Ratings for JAN Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for JAN and related companies with MarketBeat.com's FREE daily email newsletter.
